1. Home
  2. EYPT vs NEXA Comparison

EYPT vs NEXA Comparison

Compare EYPT & NEXA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EYPT
  • NEXA
  • Stock Information
  • Founded
  • EYPT 1987
  • NEXA 1956
  • Country
  • EYPT United States
  • NEXA Luxembourg
  • Employees
  • EYPT N/A
  • NEXA N/A
  • Industry
  • EYPT Biotechnology: Laboratory Analytical Instruments
  • NEXA Metal Mining
  • Sector
  • EYPT Industrials
  • NEXA Basic Materials
  • Exchange
  • EYPT Nasdaq
  • NEXA Nasdaq
  • Market Cap
  • EYPT 579.4M
  • NEXA 617.2M
  • IPO Year
  • EYPT 2005
  • NEXA 2017
  • Fundamental
  • Price
  • EYPT $10.48
  • NEXA $5.02
  • Analyst Decision
  • EYPT Strong Buy
  • NEXA Sell
  • Analyst Count
  • EYPT 8
  • NEXA 3
  • Target Price
  • EYPT $24.75
  • NEXA $5.50
  • AVG Volume (30 Days)
  • EYPT 729.0K
  • NEXA 38.8K
  • Earning Date
  • EYPT 08-06-2025
  • NEXA 08-04-2025
  • Dividend Yield
  • EYPT N/A
  • NEXA 2.02%
  • EPS Growth
  • EYPT N/A
  • NEXA N/A
  • EPS
  • EYPT N/A
  • NEXA N/A
  • Revenue
  • EYPT $56,042,000.00
  • NEXA $2,813,814,000.00
  • Revenue This Year
  • EYPT N/A
  • NEXA N/A
  • Revenue Next Year
  • EYPT N/A
  • NEXA $2.53
  • P/E Ratio
  • EYPT N/A
  • NEXA N/A
  • Revenue Growth
  • EYPT 12.04
  • NEXA 13.20
  • 52 Week Low
  • EYPT $3.91
  • NEXA $4.44
  • 52 Week High
  • EYPT $13.99
  • NEXA $9.61
  • Technical
  • Relative Strength Index (RSI)
  • EYPT 59.34
  • NEXA 53.32
  • Support Level
  • EYPT $10.26
  • NEXA $4.79
  • Resistance Level
  • EYPT $11.00
  • NEXA $5.06
  • Average True Range (ATR)
  • EYPT 0.64
  • NEXA 0.19
  • MACD
  • EYPT -0.07
  • NEXA 0.02
  • Stochastic Oscillator
  • EYPT 42.11
  • NEXA 59.37

About EYPT EyePoint Pharmaceuticals Inc.

EyePoint Pharmaceuticals Inc is a pharmaceutical company. It is engaged in developing and commercializing ophthalmic products for the treatment of eye diseases. The company has developed FDA-approved sustained-release treatments in ophthalmology. Its pre-clinical development program is focused on using its core Durasert E and Verisome technology platforms to deliver drugs to treat wet age-related macular degeneration, glaucoma, osteoarthritis, and other diseases. Geographically, the firm has operational footprints in the U.S., China, and the UK. It generates a majority of its revenue from the U.S.

About NEXA Nexa Resources S.A.

Nexa Resources SA is a low-cost integrated zinc producer. It produces copper, silver, and gold as byproducts. The company operates through two segments namely Mining and Smelting. Its Mining segment consists of various operating units includes mineral exploration activities and the production of zinc concentrates, copper concentrates and concentrates. The Smelting segment comprises operating units which include facilities recovering and refining zinc metal out of feed materials such as zinc concentrates or secondary feed materials. It generates maximum revenue from the Smelting segment. Geographically It has a presence in Brazil, Peru, the United States of America, Switzerland, Japan, Argentina, South Korea, Colombia, Vietnam, Malaysia and other countries.

Share on Social Networks: